-
Impact of Real-Time Continuous Glucose Monitoring on Medication Use and Glycemic Control in Type 2 Diabetes Across Therapy Regimens
04 Feb 2026 12:49 GMT
… medications, ≥1 pharmacy claim for the medication … Medication Use Patterns
With multiple medications available for the treatment … nephropathy, neuropathy, and cardiovascular disease.31
These findings related to medication … randomized trial. Ann Intern Med. 2017 …
-
Modified Jie-Yu-He-Huan Capsule in Post-Stroke Depression Treatment: Insights from DIA Proteomic and PRM Validation
04 Feb 2026 06:49 GMT
… employ a blind method.
Drugs and Reagents
JYHH capsule … hour following drug administration to ensure standardised pharmacokinetic conditions.
2 … shi granules in IgA nephropathy treatment.32 These methodologies have … the MJYHH capsule in treating PSD through an …
-
SCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium
03 Feb 2026 13:05 GMT
… existing and planned pharmaceutical operating companies focused … , and for treating diabetic nephropathy in certain patients … ventricular hypertrophy.
Treatment of diabetic nephropathy with an elevated … of prescription drugs to the FDA. Visit www.fda.gov…
-
Clinical Efficacy of Levocarnitine-Alprostadil Combination Therapy on Indicators of Renal Function, Oxidant-Antioxidant Balance, and Systemic Inflammation in Patients with End-Stage Diabetic Nephropathy
03 Feb 2026 08:52 GMT
… need for adjunctive pharmacological interventions that provide … interaction between the two drugs.
The observed renoprotective … treatment of diabetic nephropathy with alprostadil and calcium dobesilate. Exp Ther Med … : a randomized clinical trial. SSU_J. 2016 …
-
Patent losses hit Novartis hard, but CEO has a plan
04 Feb 2026 11:01 GMT
… trio of big-selling drugs in the last quarter … signs for Novartis' IgA nephropathy (IgAN) portfolio – led … is expecting seven pivotal trial readouts this year and … new drugs like immunology therapy ianalumab, Ionis-partnered cardiovascular drug pelacarsen …
-
The Prospects of Palmitylethanolamide in Tumor Prevention and Treatment
30 Jan 2026 23:54 GMT
… systems and combination medication regimens. Through this … means of treating tumors, but chemotherapy drugs, while … treatment, as it can precisely deliver drugs to tumor sites, increase local drug … cisplatin-induced nephropathy in mice. Mol Pharmacol. 2023; …
-
GLP-1 Receptor Agonist Therapy in Older Adults with Diabetes: A Qualitative Analysis of Phase 4 ClinicalTrials.gov Studies
03 Feb 2026 15:28 GMT
… complications such as nephropathy, retinopathy, and … standardized information on trial design, interventions, … drugs that cause glucose excretion directly from the body on mortality. Med Drug … 9. Pharmacologic approaches to glycemic treatment: standards of …
-
6 Nephrology Headlines You Missed In January 2026
03 Feb 2026 00:03 GMT
… nephropathy (IgAN), and dialysis patients.
The US Food and Drug Administration (FDA … Drug Application (sNDA) for sparsentan (Filspari) to treat … of alternative causes before treatment initiation. Lastly, the … center phase 2 clinical trial in 10 countries, …
-
MME Identified as Key Target of Notoginsenoside R1
02 Feb 2026 06:59 GMT
… effective drugs.
One … in treating diabetic nephropathy. By … nephropathy researchcomputational methods in pharmacologydiabetic kidney disease research advancementsdiabetic nephropathy treatment … pharmacology in drug discoveryNotoginsenoside R1 pharmacological …
-
Obesity’s Double Role in CKD as Comorbidity and Driver
31 Jan 2026 22:17 GMT
… at baseline.1
Clinical trial populations have also highlighted … an investigator in the FLOW trial, has observed this pattern … well. These are wonderful treatments that help address multiple sorts … in Type 2 Diabetes and Nephropathy. New England Journal of …
About
© 1995-2026